2024 annual financial data
REGENXBIO 2024 Net margin
Direct answer
Net margin was -272.54%.
Operating income was -233,346,000 USD and net income was -227,102,000 USD.
Operating cash flow was -173,125,000 USD.
Get free REGENXBIO email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 83,328,000 USD
- Operating income
- -233,346,000 USD
- Net income
- -227,102,000 USD
- Operating cash flow
- -173,125,000 USD